Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Alisha Moore"'
Autor:
Nathaniel Barry, Eng-Siew Koh, Martin A. Ebert, Alisha Moore, Roslyn J. Francis, Pejman Rowshanfarzad, Ghulam Mubashar Hassan, Sweet P. Ng, Michael Back, Benjamin Chua, Mark B. Pinkham, Andrew Pullar, Claire Phillips, Joseph Sia, Peter Gorayski, Hien Le, Suki Gill, Jeremy Croker, Nicholas Bucknell, Catherine Bettington, Farhan Syed, Kylie Jung, Joe Chang, Andrej Bece, Catherine Clark, Mori Wada, Olivia Cook, Angela Whitehead, Alana Rossi, Andrew Grose, Andrew M. Scott
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 30, Iss , Pp 100568- (2024)
Background and purpose: The [18]F-fluoroethyl-l-tyrosine (FET) PET in Glioblastoma (FIG) study is an Australian prospective, multi-centre trial evaluating FET PET for newly diagnosed glioblastoma management. The Radiation Oncology credentialing progr
Externí odkaz:
https://doaj.org/article/63aa463857ac487a8aa4e65fec51d503
Autor:
Claire Phillips, Mark B. Pinkham, Alisha Moore, Joseph Sia, Rosalind L. Jeffree, Mustafa Khasraw, Anthony Kam, Mathias Bressel, Annette Haworth
Publikováno v:
Breast, Vol 74, Iss , Pp 103675- (2024)
Introduction, A decade ago, stereotactic radiosurgery (SRS) without whole brain radiotherapy (WBRT) was emerging as preferred treatment for oligometastatic brain metastases. Studies of cavity SRS after neurosurgery were underway. Data specific to met
Externí odkaz:
https://doaj.org/article/5bbf88fff8074d858a7f8e564ecedb00
Autor:
June Corry, Alisha Moore, Liz Kenny, Chris Wratten, Tsien Fua, Charles Lin, Sandro Porceddu, Chen Liu, Michael Ruemelin, Amy Sharkey, Lachlan McDowell, Dean Wilkinson, Albert Tiong, Danny Rischin
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
IntroductionThere is no consensus as to what specifically constitutes head and neck cancer radiotherapy quality assurance (HNC RT QA). The aims of this study are to (1) describe the RT QA processes used in the TROG 12.01 study, (2) review the RT QA p
Externí odkaz:
https://doaj.org/article/eed51e51a36d492180e08acfdd75954a
Autor:
Eng-Siew Koh, Mustafa Khasraw, Elizabeth H Barnes, Kyle M Walsh, Mark Rosenthal, Rodney J Hicks, Farshad Foroudi, Hui K Gan, Anna K Nowak, Dale L Bailey, Paul Roach, Arian Lasocki, Robyn Leonard, Roel Verhaak, Andrew M Scott, Alisha Moore, Bradford A Moffat, Clare Senko, Roslyn J Francis, Martin Ebert, Sze Ting Lee, Eddie Lau, Greg Fitt, Robert Coffey, Richard De Abreu Lourenco, Lucas Adda, Paul A Thomas, Michael Back
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Introduction Glioblastoma is the most common aggressive primary central nervous system cancer in adults characterised by uniformly poor survival. Despite maximal safe resection and postoperative radiotherapy with concurrent and adjuvant temozolomide-
Externí odkaz:
https://doaj.org/article/d8d21057c5584e9388379c1d9d0c188d
Autor:
Nicholas Hardcastle, Olivia Cook, Xenia Ray, Alisha Moore, Kevin L. Moore, David Pryor, Alana Rossi, Farshad Foroudi, Tomas Kron, Shankar Siva
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Introduction Quality assurance (QA) of treatment plans in clinical trials improves protocol compliance and patient outcomes. Retrospective use of knowledge-based-planning (KBP) in clinical trials has demonstrated improved treatment plan qual
Externí odkaz:
https://doaj.org/article/d960450ddd774588be42f100da30814e
Autor:
Andrew Oar, Mark Lee, Hien Le, Kate Wilson, Chris Aiken, Lorraine Chantrill, John Simes, Nam Nguyen, Andrew Barbour, Jaswinder Samra, Katrin M. Sjoquist, Alisha Moore, David Espinoza, Val Gebski, Sonia Yip, Julie Chu, Andrew Kneebone, David Goldstein
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Among patients with non-metastatic pancreatic cancer, 80% have high-risk, borderline resectable or locally advanced cancer, with a 5-year overall survival of 12%. MASTERPLAN evaluates the safety and activity of stereotactic body r
Externí odkaz:
https://doaj.org/article/d8f2a4a7588f47168f23d3bd80749b81
Autor:
Narges Miri, Kimberley Legge, Kim Colyvas, Joerg Lehmann, Philip Vial, Alisha Moore, Monica Harris, Peter B. Greer
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background A novel remote method for external dosimetric TPS-planned auditing of intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) for clinical trials using electronic portal imaging device (EPID) has been d
Externí odkaz:
https://doaj.org/article/fa653e1bcc0a47fa8718739c3f9e0131
Autor:
Joerg Lehmann, Mohammad Hussein, Miriam A. Barry, Shankar Siva, Alisha Moore, Michael Chu, Patricia Díez, David J. Eaton, Jeffrey Harwood, Peta Lonski, Elizabeth Claridge Mackonis, Carole Meehan, Rushil Patel, Xenia Ray, Maddison Shaw, Justin Shepherd, Gregory Smyth, Therese S. Standen, Brindha Subramanian, Peter B. Greer, Catharine H. Clark
Publikováno v:
Radiotherapy and Oncology. 171:121-128
The quality of radiotherapy delivery has been shown to significantly impact clinical outcomes including patient survival. To identify errors, institutions perform Patient Specific Quality Assurance (PSQA) assessing each individual radiotherapy plan p
Autor:
Nicholas W. Bucknell, Tomas Kron, Alan Herschtal, Nicholas Hardcastle, Louis Irving, Michael MacManus, Gerard G. Hanna, Alisha Moore, Andrew Murnane, Shankar Siva, David Ball
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
Catharine H. Clark, Huiqi Yang, Coreen Corning, Joerg Lehmann, Ying Xiao, Mitsuhiro Nakamura, Romaana Mir, Sarah M. Kelly, Ingrid Kristensen, Elizabeth Miles, Martin A. Ebert, Kenton Thompson, Peter Hoskin, Coen W. Hurkmans, Alisha Moore, Angelo F. Monti, Enrico Clementel, Satoshi Ishikura, Nicolaus Andratschke, Jeff M. Michalski, Eduardo Zubizarreta, Stephen F Kry
Publikováno v:
Radiotherapy and Oncology. 150:30-39
Background and purpose The Global Quality Assurance of Radiation Therapy Clinical Trials Harmonization Group (GHG) is a collaborative group of Radiation Therapy Quality Assurance (RTQA) Groups harmonizing and improving RTQA for multi-institutional cl